ArticleMolecular therapy. Methods & clinical development2022

PAM-altering SNP-based allele-specific CRISPR-Cas9 therapeutic strategies for Huntington's disease.

Jun Wan Shin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.